Hjem › Psykiske lidelser › New Jersey
Kliniske studier for Psykiske lidelser i New Jersey
7 studier for Psykiske lidelser søker deltakere på steder i New Jersey.
Byer i New Jersey
Offisiell studietekst (engelsk)
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Clinical Site, West Long Branch
RekruttererFase 2
Alder 55 til 90 · Alle kjønn · Oppdatert 30. sep. 2026 · NCT06887192A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
- Clinical Site, Marlton
RekruttererFase 2
Alder 18 til 65 · Alle kjønn · Oppdatert 1. sep. 2026 · NCT07459647A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
- CenExel AMRI, Toms River
RekruttererFase 1
Alder 50 til 85 · Alle kjønn · Oppdatert 24. aug. 2026 · NCT06297590A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
- Clinilabs, LLC, Eatontown
- Bio Behavioral Health, Toms River
RekruttererFase 2
Alder 18 til 65 · Alle kjønn · Oppdatert 11. mai 2026 · NCT06524830A Clinical Trial to Assess the Efficacy, Safety, and Tolerability of a Repeat Dose of Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder
- Vistagen Clinical Site, Toms River
RekruttererFase 2
Alder 18 til 65 · Alle kjønn · Oppdatert 5. feb. 2026 · NCT06809179Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits
- Rutgers University Primary Care Clinics, New Brunswick
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 3. feb. 2026 · NCT06387290Open-label Extension Study in Participants With Early Alzheimer's Disease
- GSK Investigational Site, Toms River
RekruttererFase 2
Alder 50 til 85 · Alle kjønn · Oppdatert 2. feb. 2026 · NCT07105709Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.